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Summary
Historically, American Indian/Alaska Native populations (AI/AN) have suffered excess morbidity 
and mortality from influenza. We investigated the risk factors for death from 2009 pandemic 
influenza A (H1N1) among persons residing in five states with substantial AI/AN populations. We 
conducted a case-control investigation using pandemic influenza fatalities from 2009 in Alaska, 
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Arizona, New Mexico, Oklahoma and Wyoming. Controls were outpatients with influenza. We 
reviewed medical records and interviewed case proxies and controls. We used multiple imputation 
to predict missing data and multivariable conditional logistic regression to determine risk factors. 
We included 145 fatal cases and 236 controls; 22% of cases were AI/AN. Risk factors (p-value < 
0.05) included: older age (adjusted matched odds ratio [OR] 3.2, for > 45 years. vs. < 18 years), 
pre-existing medical conditions (OR 7.1), smoking (OR 3.0), delayed receipt of antivirals (MOR 
6.5), and barriers to healthcare access (OR 5.3). AI/AN race was not significantly associated with 
death. The increased influenza mortality among AI/ANs was due to factors other than racial status. 
Prevention of influenza deaths should focus on modifiable factors (smoking, early antiviral use, 
access to care) and identifying high risk persons for immunization and prompt medical attention.
Introduction
During the 2009 influenza A H1N1 pandemic (pH1N1), North American indigenous 
populations suffered disproportionately compared to the general population, as shown by 
higher rates of influenza-like illness1, hospitalization2,3,4, intensive care unit admissions4,5,6 
and a four-fold increased rate of death7. We conducted a case-control investigation to 
determine risk factors for death due to 2009 H1N1 influenza A (pH1N1) in five U.S. states 
with large American Indian/Alaska Native (AI/AN) populations. Our objectives were to 
determine: 1) whether AI/AN racial status was an independent risk factor for death and, 2) 
the risk factors for death within the AI/AN population.
Methods
This investigation was conducted in Alaska, Arizona, New Mexico, Oklahoma and 
Wyoming. Case-patients (cases) were state residents who died related to infection with 
laboratory-confirmed influenza A from April 15, 2009 through January 31, 2010. Influenza 
infection was defined by a positive polymerase chain reaction (PCR) test, viral culture 
confirming pH1N1, a rapid influenza A test, or a direct fluorescent antibody test on a 
specimen collected from April 15 through December 31, 2009. We excluded cases who had 
no contact with a health care provider in the 14 days before death, or whose death and illness 
onset occurred when the person was located outside their state.
We attempted to match cases with two control-patients based on state of residence and 
influenza specimen date (within 14 days). Controls were state residents who had laboratory-
confirmed pH1N1 infection (confirmed by PCR or culture) from April 15 through December 
31, 2009 and who were not hospitalized for influenza within 30 days after their specimen 
collection date. Cases and controls were identified from death certificates and notifiable 
disease reports. Death certificates and medical records were abstracted using a standard 
form. Additionally, we interviewed a case proxy, defined as an adult who lived with or cared 
for the case prior to their illness, or a relative or close friend who lived nearby, or a relative 
knowledgeable of the case. If no case proxy was interviewed, we abstracted seven of the 
questions from the medical record. Interviews began October 2010 and ended March 2012. 
Data on fatalities from influenza for the U.S. population was obtained from national 
surveillance.
Hennessy et al. Page 2













Four of the states required reporting of positive laboratory tests for pH1N1 (PCR and 
culture). Oklahoma obtained laboratory data from tests done by its Public Health 
Laboratory. Outpatients with pH1N1 were randomly-selected and contacted for an interview. 
Participant’s individual medical records were obtained and we abstracted demographic 
information, height, weight, health insurance status, medical and vaccination history, and 
influenza illness treatments. From interviews we obtained self-identified race, household 
characteristics, access to healthcare, past medical history, tobacco and alcohol habits, 
income and educational attainment.
Data were double entered into Paradox v 9.0 (Corel, Ottawa, Canada). Univariable tests 
were run in a conditional logistic regression model using the Wald chi-square statistic. 
Households with ≥ 1.5 persons per room were considered crowded and poverty was defined 
as having an annual household income < $25,0008. Obesity was defined as a BMI ≥30 
(adults), a BMI ≥ 95th percentile for age (2–17 year olds), or ≥ 95th percentile of weight for 
age (<2 years old). Influenza-like illness (ILI) was defined by a reported fever, and either a 
cough or a sore throat. Age was modeled using three classes (< 18, 18–44 and ≥ 45 years). 
Receipt of antiviral medications was categorized into 3 levels: none, received ≤ 2 days after 
symptom onset, received ≥ 3 days after symptom onset.
Missing data ranged from 0% (age) to 25% (income). Missing data imputation procedures 
were employed, assuming data were missing at random. Data were imputed using Markov 
chain Monte Carlo iterations assuming a multivariate normal distribution9,10,11. The 
imputation model included variables for state of residence and specimen collection date, and 
all variables in the univariable analyses and case-control membership. Dichotomous 
variables derived from continuous variables were imputed in their continuous form; other 
dichotomous variables were imputed as dichotomous indicators9,10. We created 20 imputed 
datasets for the multivariable models12. A single chain was used with 200 burn-in iterations 
and 100 iterations between datasets. Each imputed dataset was analyzed using conditional 
logistic regression and then estimates were combined accounting for the parameter 
variability estimates and the variability associated with the imputation process. Analyses 
were conducted in SAS using logistic and imputation procedures13. Multivariable models 
used purposeful forward selection and included variables with a univariate p-value < 0.2514. 
After determining main effects, all two-way interactions with appropriate sample sizes were 
evaluated for statistical significance. Variable selection was repeated on the imputed datasets 
using the combined Wald χ2 statistic that incorporated the between- and within-imputation 
variation components15. Multivariable models included: the imputation model and a 
complete case analysis, where matched pairs or observations were entered or missing based 
on whether they had missing data for any given risk factor in the model.
A multivariable model restricted to AI/AN persons evaluated a subset of factors, due to 
sample size limitations, including demographics, healthcare access, one socio-economic 
variable, and all other variables that had adequate sample sizes. The variables that were used 
to match cases and controls were considered independent predictors in this model. Model 
diagnostics were run to identify influential observations or matched pairs in terms of model 
fit and parameter point and variance estimates. All p-values were two-sided and a value < 
0.05 was considered statistically significant.
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A total of 257 fatalities associated with influenza A infection were reported in these states 
(annualized mortality: 6.6/100,000 persons/year). Of these, 145 met the case definition 
(Table 1). The epidemic peak occurred during calendar weeks 40 – 44, similar to the overall 
U.S. epidemic (Figure). Thirty-two fatalities were excluded, principally because they did not 
see a healthcare provider prior to death (90%); 69% of excluded cases were from Arizona. 
Eighty fatalities from Arizona were not included in analysis because of incomplete data or 
because Tribal approvals were not obtained. These persons were similar to the cases 
included from Arizona with regard to sex, age, diagnosis date, and underlying medical 
conditions; however, those not included were more likely to be of AI/AN racial status than 
the included fatal cases (26% vs. 11%, p = 0.01).
We recruited 236 controls; 91 (63%) cases were matched to two controls and 54 were 
matched to one control. Proxy interviews with could not be obtained for 43 (30%) of fatal 
cases. Univariate risk factors for death are shown in Table 2. Multivariable analysis 
identified four independent risk factors for a fatal infection (Table 3): older age, having a 
pre-existing medical condition, being a smoker and receiving antivirals 3 or more days after 
illness onset. Using the imputed data set, a fifth independent variable was identified: a 
financial or transportation-related barrier to healthcare access. AI/AN race was not 
significantly associated with death after adding age and preexisting conditions to the models. 
There were no significant two-way interactions between the risk factors in the final models.
Mortality risk factors for the 70 AI/AN participants are in Table 4. Multivariable analysis 
identified two independent risk factors for death: pre-existing medical conditions and obesity 
(Table 3). Using the imputed data, a third independent risk factor was identified: having been 
a smoker.
Discussion
In this case-control investigation from U.S. states with substantial AI/AN populations, we 
used medical records and interviews to assess potential risk factors for pH1N1 influenza A 
mortality. Three of the risk factors are modifiable (smoking, delayed receipt of antiviral 
medications, and a barrier to accessing health care). The association of death with smoking 
and a barrier to healthcare access have not been previously described for influenza16,17. Two 
other risk factors (older age and underlying medical conditions) are well recognized. AI/AN 
persons were overrepresented among the fatal cases (22% vs. 16% of controls, p = 0.05); 
however, AI/AN racial status was not an independent risk for death. The risk factors for 
death among the AI/AN population (pre-existing medical conditions, smoking, obesity) are 
similar to other North American populations17,18,19. This is the first population-based 
investigation to evaluate AI/AN race as a potential risk factor for influenza mortality and the 
first to evaluate influenza mortality risk factors among the AI/AN population.
Smoking has not been previously identified as a risk factor for influenza mortality16. Other 
studies of mortality risk during this pandemic either did not evaluate smoking17,18 or did not 
show an association when they compared fatal and hospitalized patients20,21. The prevalence 
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of smoking among controls (11% for those 7 years or older) was much lower than the adult 
smoking prevalence in these states, which ranges from 19.2% to 26.1%22. This could have 
led to an overestimation of the magnitude of this risk factor. Despite this potential limitation, 
smoking is a biologically plausible risk factor and should be investigated further.
The financial or transportation-related barriers to healthcare access may have caused patients 
to delay seeking care after illness-onset, resulting in more severe illness that was less 
amenable to treatment. Although 93% of the fatal cases had health insurance, insurance 
coverage differs with regard to costs paid by the patient and healthcare seeking behavior is 
complicated. Further investigation is needed to identify ways to reduce barriers to healthcare 
among high-risk individuals, with and without health insurance.
Whether AI/AN race is, by itself, a risk factor for death or is a marker for other factors has 
substantial implications. Finding that AI/AN racial status was a risk factor might imply an 
undiscovered genetic susceptibility to severe influenza. A genetic explanation offers limited 
prevention options and could have a chilling effect on efforts to reduce influenza mortality 
among AI/AN23. Because AI/AN race is a marker for other risk factors, we can now focus 
on those modifiable risks among AI/AN persons. Three risk factors from the AI/AN-specific 
model were common among fatal cases (obesity 61%, smoking 35%, pre-existing conditions 
69%). Similar to the overall population, we observed trends among AI/AN persons for 
higher mortality for older age, delay in antivirals (cases 36%, controls 9%), and healthcare 
access barriers (cases 35%, controls 11%). Accessing healthcare is a problem for AI/AN 
persons with influenza1. Among adults in 2009, AI/AN persons had the highest frequency of 
influenza-like illness of any racial group (16.2% vs. 8.2% overall), yet were the least likely 
to seek healthcare (37.4% vs. 42.1% overall). Further efforts are indicated to improve access 
and healthcare seeking behavior among AI/AN persons. Environmental determinants for 
lower respiratory tract infections common among AI/AN populations deserve further 
attention. These include household crowding24,25, limited access to in-home water and 
sanitation services26,27,28, and household air pollution from wood-burning stoves or second-
hand tobacco smoke29.
The influenza mortality disparity between AI/AN persons and the general population is a 
challenge for influenza preparedness30. Prior to 2009, AI/ANs were not prioritized to receive 
vaccine or antiviral medications on the basis of racial status in the US. However, 
recommendations now include AI/AN persons as a high-risk group31,32. Some might 
consider that a risk factor-based strategy would be sufficient to identify AI/AN persons at 
risk for influenza complications. However, using the criteria for receipt of antiviral 
medications, 30% of fatal AI/AN cases would not have been considered high risk. In 
contrast, only 16% of influenza fatalities among whites would not have been considered 
high risk. AI/AN persons during 2009 also suffered disproportionately from influenza 
illness, hospitalizations and intensive care unit admissions. This is similar to the experience 
of AI/AN persons throughout the past 2 decades33. Thus, a risk factor-based strategy may 
not be comprehensive enough to address these long-standing influenza disparities. 
Designating AI/AN persons as high-risk can allow a more rapid delivery of vaccine, antiviral 
medications and education through U.S. Indian Health Service, tribal and urban Indian 
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clinics. Thus, maintaining the high risk designation may be more likely to reduce the health 
disparity than a risk factor-based approach.
Influenza immunization uptake among AI/AN persons is similar to the general United States 
population, but should be improved34,35. Efforts to reduce smoking prevalence and obesity 
among AI/AN persons may be beneficial in reducing influenza mortality. Smoking 
prevalence among AI/AN adults (31.4%) far exceeds the overall U.S. population (19.0%)36. 
Likewise, obesity among AI/AN adults (39.6% prevalence) is more common that among 
non-Hispanic whites (26%)37.
These findings may not be generalizable to the entire U.S. or to all AI/AN persons. Because 
controls had access to health care and telephone service, comparisons for related 
socioeconomic factors may have been limited by design. By modelling only three age 
categories our ability to detect gradations in risk within age classes is limited. Missing data 
was addressed through multiple imputation which improved the power but would not solve 
potential bias related to representativeness of the population. We may have underestimated 
the AI/AN persons among the fatalities, since misclassification of AI/AN decedents has 
been documented38. Since approval was not obtained from all Arizona tribes, there was 
systematic under-recruitment of AI/AN persons and reduced representativeness of the 
included cases. Glucocorticoids used as a fever-reducing agent was identified as a risk factor 
for influenza death in China39. This is not a recommended practice in the United States40. 
However, because we did not obtain the timing or dosage of corticosteroid administration 
and nearly 50% of the fatal cases had received steroids, this remains a potential, 
uncontrolled confounder.
During the 2009 pandemic, AI/AN racial status was not independently associated with 
death, but was a marker for other modifiable factors. Keeping AI/AN race among the high-
risk conditions for influenza complications should be considered as an appropriate response 
to the elevated risk of morbidity and mortality in this population. Increased efforts to reduce 
influenza mortality are needed to address this longstanding health disparity.
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Female 73 (50%) 120 (54%)a
Male 72 (50%) 104 (46%)
Age Group
< 5 years 9 (6%) 32 (14%)
5–10 years 4 (3%) 33 (14%)
11–20 years 14 (10%) 52 (22%)
21–30 years 19 (13%) 50 (21%)
31–40 years 9 (6%) 23 (10%)
41–50 years 23 (16%) 21 (9%)
51–60 years 35 (24%) 17 (7%)
61–70 years 14 (10%) 5 (2%)
70+ years 18 (12%) 3 (1%)
State
Alaska 11 (8%)  22 (9%)
Arizona 47 (32%) 49 (21%)
Oklahoma 37 (26%) 74 (31%)
New Mexico 47 (32%) 85 (36%)
Wyoming 3 (2%) 6 (3%)
Residence Typeb
Urban 3 (4%) 19 (9%)
Large Rural 17 (19%) 81 (38%)
Small Rural 8 (9%) 16 (8%)
Isolated 60 (68%) 94 (45%)
Race (when asked for a single race)
AI/AN 25 (17%) 27 (11%)
White 110 (76%)  169 (72%)
Asian 0 (0%) 14 (6%)
Black 5 (4%) 3 (1%)
Other 3 (2%) 23 (10%)c
Unknown 2 (1%) 0 (0%)
AI/AN race (alone or in combination) 32 (22%) 38 (16%)
Specimen Collection Date
Summer (May – Aug) 17 (12%) 27 (11%)
Fall (Sept – Oct) 96 (66%) 170 (72%)
Late Fall (Nov – Dec) 32 (22%) 39 (17%)
Number of Controls per Case
1 54 (37%)
2 91 (63%)
Time from specimen collection date of case and matched controls ≤ 14 days 193 (82%)


















15 – 30 days 14 (6%)
31 – 60 days 13 (5%)
≥ 60 days 16 (7%)
Number and % of cases without an interview of the case-proxy 43 (29.7%)    
Diagnostic Test for Influenzad
Culture 28 (19%) 10 (4%)
PCR 98 (68%) 209 (89%)
Rapid enzyme immunoassay 16 (11%) 15 (6%)
Fluorescent AB 3 (2%) 2 (1%)
a
Twelve outpatient controls did not have a chart review completed and sex was not determined.
b
Residence type only available on 88 (61%) of the cases and 210 (89%) of the controls.
c
22 persons listed “Hispanic” as their race and one person listed “Filipino”
d
Results reflect medical chart review results. All controls were reported to the state health department as having a positive culture or PCR for 
pH1N1.




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Epidemiol Infect. Author manuscript; available in PMC 2017 January 09.
